Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Arvinas, Inc.
IPO Date: September 24, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $540.14M
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.09 | 2.96%
Avg Daily Range (30 D): $0.16 | 2.08%
Avg Daily Range (90 D): $0.22 | 3.01%
Institutional Daily Volume
Avg Daily Volume: .53M
Avg Daily Volume (30 D): 1.59M
Avg Daily Volume (90 D): 2.15M
Trade Size
Avg Trade Size (Sh.): 70
Avg Trade Size (Sh.) (30 D): 103
Avg Trade Size (Sh.) (90 D): 101
Institutional Trades
Total Inst.Trades: 3,014
Avg Inst. Trade: $2.18M
Avg Inst. Trade (30 D): $2.03M
Avg Inst. Trade (90 D): $1.78M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.64M
Avg Closing Trade (30 D): $2.01M
Avg Closing Trade (90 D): $2.02M
Avg Closing Volume: 80.17K
   
News
Jun 13, 2025 @ 11:00 AM
Arvinas Presents Preclinical Data for PROTAC BCL6 ...
Source: N/A
Jun 6, 2025 @ 11:00 AM
Arvinas Announces Submission of New Drug Applicati...
Source: N/A
May 6, 2025 @ 10:00 PM
Kirby McInerney LLP Announces Investigation of Cla...
Source: N/A
Apr 30, 2025 @ 5:00 PM
Metastatic HR+/HER2- Breast Cancer Market—T...
Source: Delveinsight
Apr 4, 2025 @ 11:00 AM
Arvinas Presents First-in-Human Data for Investiga...
Source: N/A
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $1.14 $-.68
Diluted EPS $1.14 $-.68
Revenue $ $ 188.8M $ 102.4M
Gross Profit $ $ $
Net Income / Loss $ $ 82.9M $ -49.2M
Operating Income / Loss $ $ 71.4M $ -60.3M
Cost of Revenue $ $ $
Net Cash Flow $ $ -19.5M $ -75.1M
PE Ratio